The main US indices (+ 1.38% on the S & P500, + 1.39% on the Nasdaq-100 and + 0.98% on the Dow Jones) ended the session sharply higher.
(CercleFinance.com) – The main American indices (+ 1.38% on the S & P500, + 1.39% on the Nasdaq-100 and + 0.98% on the Dow Jones) ended the session sharply higher, after a three-day weekend due to the closure Friday to Christmas Eve.
The S & P500 (around 4.791Pts) smashes a 69th annual record, with a double closing / intraday (it validates a score above 4.744 at the close).
In the absence of major macroeconomic data, the stock market news of the coming days could once again be punctuated by the file of the Covid-19 pandemic and the consequences of the Omicron variant on the economic recovery.
‘The cancellation of several thousand flights in the United States on Sunday as well as the return to port, according to several media, of at least three cruise ships due to cases of Covid-19 on board are fueling concerns’, underlines- do we also at Kiplink Finance.
However, some confidence continues to prevail in this case, after preliminary data from various studies, published last week, showing that Omicron remains less likely to lead to hospitalizations than Delta.
In securities news, Merck and Ridgeback announced on Friday that they had received special emergency approval in Japan for molnupiravir, their investigational drug for infectious diseases caused by SARS-CoV-2.
Boeing said it won a contract worth more than $ 239 million from the US military to re-engine Apache attack helicopters assembled by the aeronautics and defense giant.
Moderna announced that the Swiss federal government has exercised its option to purchase an additional seven million doses of Moderna’s booster vaccine for delivery in the second half of 2022.
These doses are in addition to the seven million initial doses of the booster vaccine that the Swiss Confederation has agreed to purchase for delivery in 2022 and bring Switzerland’s order commitment to a total of 27.5 million doses.
News Corp announces an agreement to acquire the Base Chemicals business from S&P Global and IHS Markit for $ 295 million in a cash transaction, subject to customary adjustments.
Copyright (c) 2021 CercleFinance.com. All rights reserved.